There’s just one week left before Xconomy’s latest biotech event, “What’s Hot in Seattle Biotech.” Don’t let the clock run out while you can still save some cash on a ticket.
Next Tuesday, June 12, we’re bringing together some of the Emerald City’s top life science entrepreneurs, scientists, and investors to discuss the strengths and challenges of Seattle’s life science community. Don’t wait to register—our Procrastinator’s Special ends soon and it’s your last chance at a discount.
Leen Kawas, CEO, M3 Biotechnology
Harlan Robins, Co-founder & Head of Innovation, Adaptive Biotechnologies
Desney Tan, General Manager, Microsoft Healthcare NExT
Claudia Mitchell, CEO, Universal Cells
Peter Thompson, Chairman, Silverback Therapeutics
Ivan Liachko, CEO, Phase Genomics
Lara Mangravite, President, Sage Bionetworks
Nicholas Mark, Medical Director, KenSci
VK Gadi, Medical Director & Co-Founder, SEngine Precision Medicine
Maura Little, Executive Director, Cambia Grove
Jon Congleton, CEO, Impel NeuroPharma
Amy Bernard, Product Architect, Allen Institute for Brain Science
Dan Wattendorf, Director of Innovative Technology Solutions, Bill & Melinda Gates Foundation
Heather Franklin, President & CEO, Blaze Bioscience